Evidence map›Paper›PMID 40691212›Full record

ArticleScientific reports2025

Pd(0)-Sb@A@SiO

Anjan Kumar, Ahmed M Naglah, Chou-Yi Hsu, Jayanti Makasana, Suhas Ballal, Munther Kadheem, Abhayveer Singh, T Krithiga, Swati Mishra, Pushpa Negi Bhakuni

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anjan KumarDepartment of Electronics and Communication Engineering, GLA University, Mathura, 281406, India.
Ahmed M NaglahDrug Exploration and Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, 11451, Riyadh, Saudi Arabia. anaglah@ksu.edu.sa.
Chou-Yi HsuThunderbird School of Global Management, Arizona State University Tempe Campus, Phoenix, AZ, 85004, USA.
Jayanti MakasanaDepartment of Chemistry, Faculty of Science, Marwadi University Research Center, Marwadi University, Rajkot, 360003, Gujarat, India.
Suhas BallalDepartment of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
Munther KadheemCollege of Pharmacy, the Islamic University, Najaf, Iraq.
Abhayveer SinghCentre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, 140401, Punjab, India.
T KrithigaDepartment of Chemistry, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Swati MishraDepartment of Pharmacology IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to Be University), Bhubaneswar, Odisha, 751003, India.
Pushpa Negi BhakuniDepartment of Allied Science, Graphic Era Hill University, Bhimtal, Uttarakhand, 248002, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A highly efficient magnetic nanocatalyst has been developed by covalently grafting a Pd(0)-Sb@A complex onto a silica-coated nickel ferrite support. This innovative nanocatalyst has been thoroughly analyzed using various techniques, including FT-IR, VSM, XRD, ICP, EDX, XPS, TEM, and FE-SEM. Its performance was then evaluated in the synthesis of symmetrical sulfides and unsymmetrical ether derivatives. Key advantages of this approach include high product yields, reduced reaction times, straightforward synthesis, easy magnetic separation, and excellent catalyst recoverability, maintaining activity for at least four cycles without notable degradation.

Indexed as

ComplexCouplingNanoparticlesNiFe2O4Schiff base

Identifiers

PMID40691212
PMCPMC12280156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.